A detailed history of Deka Bank Deutsche Girozentrale transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 41,000 shares of ALXO stock, worth $61,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,000
Previous 41,000 -0.0%
Holding current value
$61,090
Previous $468,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$4.37 - $9.56 $72,979 - $159,652
16,700 Added 68.72%
41,000 $301,000
Q1 2022

Apr 28, 2022

BUY
$13.65 - $22.06 $30,030 - $48,532
2,200 Added 9.95%
24,300 $421,000
Q4 2021

Feb 02, 2022

BUY
$21.49 - $74.4 $12,893 - $44,640
600 Added 2.79%
22,100 $485,000
Q3 2021

Oct 22, 2021

BUY
$52.51 - $80.91 $577,610 - $890,010
11,000 Added 104.76%
21,500 $1.58 Million
Q4 2020

Mar 12, 2021

BUY
$34.11 - $112.26 $358,155 - $1.18 Million
10,500 New
10,500 $886,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $60.7M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.